SA

Salahuddin Ahmed

Johns Hopkins Bloomberg School of Public Health, Projahnmo Research Foundation, University of Edinburgh, Dhaka Medical College and Hospital, Johns Hopkins University Bangladesh, Projahnmo

Research areas: Medicine · Pediatrics, Perinatology and Child Health · Global Maternal and Child Health · Pneumonia and Respiratory Infections · Maternal and Neonatal Healthcare

ORCID iD 0000-0001-6771-0638
Follow

About

Dr Salahuddin Ahmed is a medical doctor with a PhD in global health from the University of Edinburgh and a public health epidemiologist with over 25 years of experience designing and managing epidemiological studies, disease surveillance, monitoring and evaluating public health programs. His research focuses on improving the health and nutritional status of newborns, children, and women in low-resource settings by enhancing understanding of the major causes of neonatal, child, and maternal morbidity, mortality, and malnutrition, and by designing and testing cost-effective public health interventions to address them. The design and scope of his studies are diverse, ranging from formative research to implementation research to randomized clinical trials. His research also focuses on integrating and strengthening the health system in low- and middle-income countries.
He serves as Executive Director and Scientist of Projahnmo Research Foundation, Bangladesh. Before that, he was a Research Director at Johns Hopkins University, Bangladesh. He also worked at CARE Bangladesh, Johns Hopkins Bloomberg School of Public Health, Department of International Health, Jhpiego, Population Council, and Mitra and Associates.
He is a member of the National Research Ethics Committee of the Bangladesh Medical Research Council, the highest research ethics committee in Bangladesh. He is also a member of the Integrated Management of Childhood Illness working group and the National Technical Working Committee for Newborn Health in Bangladesh. He is an Associate in the Department of International Health of Johns Hopkins Bloomberg School of Public Health, MD, USA.
In 2018, he was awarded a fellowship from the National Institute for Health Research (NIHR) Global Health Research Unit on Respiratory Health (RESPIRE) to pursue postgraduate studies (PhD) at the University of Edinburgh, Scotland, UK. In 2022, he received the Young Investigator Award at the 12th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) in Toronto, Canada. In 2023, he obtained a travel grant from the American Thoracic Society to attend the Annual Scientific Meeting in Washington, DC, USA.

Employment

  • Johns Hopkins Bloomberg School of Public Health Associate
    2022 - Present
  • Projahnmo Research Foundation Scientist and Executive Director
    2019 - Present
  • Johns Hopkins University Bangladesh, Projahnmo Director Research
    2015 - 2018
  • Care Bangladesh National Nutrition Coordinator
    2013 - 2015
  • Johns Hopkins Bloomberg School of Public Health Program Manager
    2007 - 2013
  • Population Council Program Officer
    2006 - 2007
  • Mitra and Associates Research Coordinator
    2001 - 2006

Education

Projects & Funding

  • Implementing the World Health Organization Labour Care Guide in A Selected Hospital of Bangladesh: A Mixed-Methods Evaluation Burnet Institute
    2026 - 2027
  • Climate Change, Lung Function, and Respiratory Disease Patterns in the Adult Population of Sylhet, Bangladesh The UK National Institute for Health Research (NIHR) through Global Health Research Unit on Respiratory Health (RESPIRE) at the University of Edinburgh
    2025 - 2026
  • Leveraging community-to-facility service provision to implement the World Health Organization HEARTS-D guidelines in Sylhet, Bangladesh for improving diabetes control and prevention NIH
    2025 - 2029
  • The E-Patient Quality Improvement & Standardization—EQIS— Platform to Improve Clinical Care in Bangladesh: An Intervention Study Peabody Health Philanthropy
    2024 - 2026
  • Bangladesh Lung Auscultation with Artificial Intelligence for Antibiotic Stewardship: Randomized Controlled Trial (The BLAAAST Trial) NIH
    2024 - 2029
  • Integrating immediate Kangaroo Mother Care into district hospitals with a level 2 neonatal intensive care unit: Implementation Research WHO
    2023 - 2026
  • A Phase 2/3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus (RSV), in Adults ≥ 60 Years of Age Moderna
    2022 - 2025
  • Nutritional management of growth faltering in infants aged under six months in Asia and Africa: An individually randomized trial World Health Organization
    2022 - 2025
  • Implementation Research to Scale-up and Evaluate the Impact of Antenatal Corticosteroids on Preterm Newborn Outcomes World Health Organization
    2022 - 2027
  • A Phase III, randomized, double-blind, placebo controlled multi-country study to demonstrate efficacy of a single dose of unadjuvanted RSV Maternal vaccine, administered IM to pregnant women 18 to 49 years of age, for prevention of RSV associated LRTI in… GlaxoSmithKline
    2021 - 2023
  • A multi-country, multi-centre, three-arm, parallel group, double-blind, placebo-controlled, randomized trial of two doses of antenatal corticosteroids for women with a high probability of birth in the late preterm period in hospitals in low-resource coun… World Health Organization
    2021 - 2025
  • Optimizing place of treatment and antibiotic regimens for young infants presenting with signs of possible serious bacterial infection World Health Organization
    2020 - 2024
  • Field-testing and validation of the Global Scales of Early Development (GSED) for 0-3-year-old children World Health Organization
    2019 - 2022
  • Digital Auscultation and Pulmonary Function Testing Among Rural Bangladeshi Infants National Institute of Environmental Health Sciences
    2019 - 2022
  • Community use of digital auscultation to improve diagnosis of paediatric pneumonia in Sylhet, Bangladesh UK National Institute for Health Research (NIHR) (Global Health Research Unit on Respiratory Health (RESPIRE)
    2018 - 2022
  • A multi-country, multicenter, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent early and late preterm birth in hospitals in low-resource countries to improve newborn outcomes World Health Organization
    2017 - 2020
  • A Randomized, Placebo-Controlled Study to Determine the Immunogenicity and Safety of Immunization with RSV F Vaccine in Third-trimester Pregnant Women; and Safety and Efficacy of Maternally Transferred Antibodies in Preventing RSV Disease in Infants Novavax
    2017 - 2019

Publications (128)